Reaction to this week's political shocks, why many conservatives are choosing to double down on Trump critics, and then, a conversation on the growing dis-union in America.
Macular degeneration is one of the most common causes of blindness in older Americans. Between 10 million and 15 million people in the U.S. have some form of the eye disease. As baby boomers age, doctors expect those numbers to climb sharply. There is no cure, but early diagnosis and treatment can help slow the progression of the disease. A limited number of people have had success improving their vision with the aid of a tiny telescope implanted behind the iris. Others receive drug injections directly into the eye. And there’s promising work being done in stem cell research. Experts talk about the latest in treating macular degeneration.
- Jim Hindman Founder of Jiffy Lube and author of "Was Blind, But Now I See: Life Stories (and Lessons) in My Fight against Age-Related Macular Degeneration."
- Dr. Judith Goldstein Director of Vision Rehabilitation Services at the Wilmer Eye Institute, Johns Hopkins University; assistant professor of Ophthalmology and Rehabilitation Medicine, Johns Hopkins University.
- Dr. Julia Haller Ophthalmologist-in-chief of the Wills Eye Hospital in Philadelphia and one of the nation's leading retina surgeons and researchers.
Most Recent Shows
Political fallout from the dismissal of FBI director James Comey, how our government created racially segregated cities, and a young Palestinian's perspective on Mideast peace.
Washington Post reporter Dan Balz on covering President Trump and linguist Deborah Tannen on how women support each other with the words they use.
American University history professor Allan Lichtman describes how and why President Donald Trump could be impeached, and then, Pulitzer Prize winning writer Elizabeth Strout on her new book, "Anything is Possible".